<DOC>
	<DOC>NCT02247427</DOC>
	<brief_summary>The purpose of this study is to determine clinical outcomes related to deactivation of Cardiac Resynchronization Therapy device in subjects with super response.</brief_summary>
	<brief_title>Clinical Outcomes Related to Cardiac Resynchronization Therapy Deactivation of Super Responders</brief_title>
	<detailed_description />
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>super response to Cardiac Resynchronization Therapy near normal Left ventricular ejection fraction &gt;99% pacing &lt;99% pacing atrial fibrillation ischemic cardiomyopathy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Super responder</keyword>
</DOC>